ÂÜÀòÂÒÂ×

Ian Wisenberg is a seasoned executive in the life sciences sector, currently serving as a Board Member at LBT Innovations Ltd, where innovative AI-based culture plate readers for environmental monitoring are developed. As Executive Director at TRIOVANCE, Wisenberg focuses on gene and cell therapies for diabetic foot ulcers. Additionally, Wisenberg is a Business Advisor at BiomeBank and the Founder and Managing Director of BioGlobal Consulting Group, which provides strategic solutions for life science companies. Previously, Wisenberg held leadership roles including Executive Chairman and CEO at BioCina, Operating Partner at Bridgewest Group, and Chief Business Officer positions at BioArdis and Bridgewest Australia Holdings. Educational credentials include a Bachelor of Commerce in Accounting from the University of Cape Town.